Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.

IF 3 4区 医学 Q3 Biochemistry, Genetics and Molecular Biology
Aida Orois, Celia Badenas, Jordi L Reverter, Verónica López, Miriam Potrony, Mireia Mora, Irene Halperin, Josep Oriola
{"title":"Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.","authors":"Aida Orois,&nbsp;Celia Badenas,&nbsp;Jordi L Reverter,&nbsp;Verónica López,&nbsp;Miriam Potrony,&nbsp;Mireia Mora,&nbsp;Irene Halperin,&nbsp;Josep Oriola","doi":"10.1007/s12672-020-00383-5","DOIUrl":null,"url":null,"abstract":"<p><p>To date, the genes involved in familial non-medullary thyroid cancer (FNMTC) remain poorly understood, with the exception of syndromic cases of FNMTC. It has been proposed that germline mutations in telomere-related genes, such as POT1, described in familial melanoma might also predispose individuals to thyroid cancer, requiring further research. We aimed to identify germline mutations in POT1 in selected FNMTC families (with at least three affected members) without a history of other cancers or other features, and to describe the clinical characteristics of these families. Sequencing of the 5'UTR and coding regions of POT1 was performed in seven affected people (index cases) from seven families with FNMTC. In addition, we performed whole-exome sequencing (WES) of DNA from 10 affected individuals belonging to four of these families. We did not find germline variants of interest in POT1 by Sanger sequencing or WES. We neither found putative causative mutations in genes previously described as candidate genes for FNMTC in the 4 families studied by WES. In our study, no germline potentially pathogenic mutations were detected in POT1, minimizing the possibilities that this gene could be substantially involved in non-syndromic FNMTC.</p>","PeriodicalId":13060,"journal":{"name":"Hormones & Cancer","volume":"11 2","pages":"111-116"},"PeriodicalIF":3.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12672-020-00383-5","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormones & Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-020-00383-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 9

Abstract

To date, the genes involved in familial non-medullary thyroid cancer (FNMTC) remain poorly understood, with the exception of syndromic cases of FNMTC. It has been proposed that germline mutations in telomere-related genes, such as POT1, described in familial melanoma might also predispose individuals to thyroid cancer, requiring further research. We aimed to identify germline mutations in POT1 in selected FNMTC families (with at least three affected members) without a history of other cancers or other features, and to describe the clinical characteristics of these families. Sequencing of the 5'UTR and coding regions of POT1 was performed in seven affected people (index cases) from seven families with FNMTC. In addition, we performed whole-exome sequencing (WES) of DNA from 10 affected individuals belonging to four of these families. We did not find germline variants of interest in POT1 by Sanger sequencing or WES. We neither found putative causative mutations in genes previously described as candidate genes for FNMTC in the 4 families studied by WES. In our study, no germline potentially pathogenic mutations were detected in POT1, minimizing the possibilities that this gene could be substantially involved in non-syndromic FNMTC.

家族性非髓样甲状腺癌家族中缺乏POT1基因突变。
迄今为止,家族性非髓样甲状腺癌(FNMTC)的相关基因仍然知之甚少,除了FNMTC的综合征病例。有人提出,家族性黑色素瘤中描述的端粒相关基因(如POT1)的种系突变也可能使个体易患甲状腺癌,这需要进一步的研究。我们的目的是在没有其他癌症病史或其他特征的FNMTC家族(至少有三个受影响的成员)中鉴定POT1的种系突变,并描述这些家族的临床特征。对来自7个FNMTC家族的7名患者(索引病例)进行了5'UTR和POT1编码区测序。此外,我们对来自其中四个家族的10个受影响个体的DNA进行了全外显子组测序(WES)。我们没有通过Sanger测序或WES发现POT1感兴趣的种系变异。在WES研究的4个家族中,我们没有发现先前被描述为FNMTC候选基因的推定致病突变。在我们的研究中,在POT1中未检测到潜在的生殖系致病突变,从而最大限度地降低了该基因实质性参与非综合征性FNMTC的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hormones & Cancer
Hormones & Cancer ONCOLOGY-ENDOCRINOLOGY & METABOLISM
CiteScore
4.60
自引率
0.00%
发文量
0
期刊介绍: Hormones and Cancer is a unique multidisciplinary translational journal featuring basic science, pre-clinical, epidemiological, and clinical research papers. It covers all aspects of the interface of Endocrinology and Oncology. Thus, the journal covers two main areas of research: Endocrine tumors (benign & malignant tumors of hormone secreting endocrine organs) and the effects of hormones on any type of tumor. We welcome all types of studies related to these fields, but our particular attention is on translational aspects of research. In addition to basic, pre-clinical, and epidemiological studies, we encourage submission of clinical studies including those that comprise small series of tumors in rare endocrine neoplasias and/or negative or confirmatory results provided that they significantly enhance our understanding of endocrine aspects of oncology. The journal does not publish case studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信